Skin and Mucosal Diseases I Flashcards

1
Q

Ectodermal dysplasia
(2)

A

 Two or more ectodermally derived structures fail to develop
- Hair, skin, nails, teeth, sweat glands, salivary glands
 AD, AR, X-linked inheritance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ectodermal dysplasia
 Clinical features:
 Hypohidrotic ectodermal dysplasia:
(5)

A

 Male predominance
 Reduced number of sweat glands → cannot regulate heat
 Sparse hair, reduced eyebrows, eyelashes
 Salivary glands may be hypoplastic or absent
 Teeth – hypodontia, abnormal shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ectodermal dysplasia
Treatment: (2)

A

genetic counseling, prosthetic appliances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

White sponge nevus
 Defect in
 inheritance
 mutations

A

the normal keratinization of oral mucosa
AD
Keratin 4, Keratin 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

White sponge nevus
 Clinical features:
who
appearance
appearance
MC
where (5)

A

 Usually appear at birth, early childhood
 Symmetrical, thickened plaques
 White, corrugated appearance
 MC buccal mucosa bilaterally
 Ventral tongue, labial mucosa, soft palate, alveolar mucosa, FOM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

White sponge nevus
Treatment:

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ehlers-Danlos syndrome
(2)

A

 Connective tissue disorder, production of abnormal collagen
 Many genes involved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ehlers-Danlos syndrome
 Clinical features:
(5)

A

 Hyperelasticity of the skin, cutaneous fragility
 Hypermobility of joints – remarkable flexibility
 Patients may bruise easily
 Gorlin sign: touch the tip of the nose with tongue! (50% of patients)
 Type VIII – rare type, periodontal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ehlers-Danlos syndrome
Treatment: Depends on subtype
 Mild type:

A

compatible with normal life span

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Peutz-Jeghers syndrome
(2)

A

 AD inheritance
 Mutations in tumor-suppressor gene – STK11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Peutz-Jeghers syndrome
 Clinical features:
(4)

A

 Pigmented lesions on periorificial areas (mouth, nose, anus, genital region) and
extremities
 Intestinal polyps – may develop into adenocarcinoma
 Increased frequency of other malignancies
 Intraoral lesions: buccal mucosa, labial mucosa, tongue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Peutz-Jeghers syndrome
 Treatment:

A

patients should be monitored for tumor development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Epidermolysis bullosa
(3)

A

 Mucocutaneous disease, several types
 Genetic mutation
 Defect in attachment mechanisms of epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Epidermolysis bullosa
 Clinical features:
(3)

A

 Vesicles and bullae develop from low-grade trauma
 Result in erosions and ulcerations that cause scarring
 Minor forms and severe forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Epidermolysis bullosa
 Oral: (3)

A

gingival erythema, recession, loss of vestibule depth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Epidermolysis bullosa
 Treatment:

A

wound care, antibiotics, surgery
 Recommend noncariogenic diet (soft foods), atraumatic oral hygiene
procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Behçet syndrome
(Behçet Disease)
 Combination of (3)
 Abnormal immune process triggered by
 Genetic predisposition –

A

chronic ocular inflammation, oro-genital ulcerations, and
systemic vasculitis
an infectious or environmental antigen
HLA-B51

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Behçet syndrome
(Behçet Disease)
 Clinical features:
 MC age
 Increased prevalence in (gender)
 Most patients have
 Ulcerations may appear similar to
 Usually surrounded by a
 Genital lesions:

A

3rd and 4th decade
males
oral ulcerations
aphthous stomatitis
larger area of erythema
irregular ulcerations

19
Q

Behçet syndrome
(Behçet Disease)
 Clinical features:
 Vascular disease:
 Cutaneous lesions: (3)
 Ocular involvement: (4)
 Blindness occurs in –% patients
 CNS involvement: includes (2)

A

veins affected more frequently – inflammation, thrombi
erythematous papules, vesicles, pustules
uveitis, conjunctivitis, corneal ulceration, arteritis
25
paralysis and dementia

20
Q

Behçet syndrome
(Behçet Disease)
 Treatment:

A

may require systemic meds (corticosteroids,
immunosuppressants)

21
Q

Reactive Arthritis
Reiter syndrome
(2)

A

 Likely an immunologically mediated disease, triggered by an infectious
agent
 Genetic predisposition – HLA-B27

22
Q

Reactive Arthritis
Reiter syndrome
 Clinical features:
(2)

A

 Prevalent in young adult men
 Triad:

23
Q

 Triad:

A

 Urethritis (often first sign)
 Arthritis –usually affects joints of lower extremities
 Conjunctivitis

24
Q

Reactive Arthritis
Reiter syndrome
 Clinical features:
 Oral:
 Skin lesions:

A

erythematous papules, shallow ulcers
 Tongue, buccal mucosa, palate, gingiva

on penis – balanitis circinata:
 Similar appearance to geographic tongue

25
Reactive Arthritis Reiter syndrome  Treatment:
NSAIDS for managing arthritis, corticosteroids, immunosuppressants
26
Psoriasis  US  Problem?  (2) factors may play a role  Prevalence of --- appears to be higher than general population
Chronic skin disease, affects 2% of US population Increased proliferative activity of cutaneous keratinocytes Genetic and environmental erythema migrans
27
Psoriasis  Clinical features:  Onset during  How long?  MC on  Appearance  Lesions improve during --- and worsen during the ---
2nd-3rd decade Persists for years, with periods of exacerbation and inactivity scalp, elbows, knees – often symmetrically distributed Well-demarcated, erythematous plaque with silvery scale on surface summer, winter
28
Psoriasis Treatment:
topical corticosteroids for moderate involvement
29
Lupus erythematosus (2)
 Immune mediated condition  Common connective tissue disease in the US
30
 Systemic lupus erythematosus (SLE):
multisystem disease: solid organs, cutaneous and oral manifestation
31
 Chronic cutaneous lupus erythematosus (CCLE):
primarily affects skin and oral mucosa
32
Lupus erythematosus  Clinical features: (SLE) gender age symptoms (4) symptom --- may exacerbate lesion
 Females: 8-10x more common  MC diagnosis in 4th decade  Fever, weight loss, arthritis, fatigue  Butterfly rash (erythematous rash) over malar area and nose (40-50% patients)  Sunlight
33
Lupus erythematosus  Clinical features (SLE): (2)
 Kidneys affected (40-50% patients) – may lead to kidney failure  Cardiac involvement - endocarditis
34
Lupus erythematosus (SLE)  Oral lesions:
may appear lichenoid, erythema and ulcerations may be present  often nonspecific  palate, buccal mucosa, lips, gingiva
35
Lupus erythematosus  Clinical features (CCLE): (3)
 Few or no systemic signs or symptoms  Lesions limited to skin or mucosal surfaces  Skin lesion: scaly, erythematous patches (sun-exposed skin)
36
Lupus erythematosus (CCLE)  Oral lesions:
lichenoid appearance  Rarely occur in absence of skin lesions
37
Lupus erythematosus  Diagnosis:
 Antibodies directed against double-stranded DNA (70% SLE patients)
38
Lupus erythematosus Treatment:  Avoid  Mild cases may be managed with  Severe cases:  Prognosis depends on
excessive sunlight exposure NSAIDS systemic corticosteroids, immunosuppressive medications organs affected
39
Angioedema   involves  MC cause: 
Diffuse, edematous swelling of soft tissue subcutaneous and submucosal connective tissue mast cell degranulation → histamine release IgE-mediated hypersensitivity (drugs, foods, plants, dusts)
40
Angioedema  Alternative mechanism:
ACE inhibitors (0.1 – 0.2%)  Excess bradykinin
41
Angioedema  Clinical features:  Rapid onset of  MC in  ACE-inhibitor associated angioedema:
soft, nontender tissue swelling extremities, also face, neck, trunk, genitals frequently affects H&N - Face, lips, tongue, FOM, pharynx, larynx - 3-4x Black patients
42
Angioedema  Diagnosis:
 Clinical presentation and determination of antigenic stimulus
43
Angioedema  Treatment:  Allergic:  ACE-inhibitor:
oral antihistamine therapy avoid all medications in drug class